Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals : A stratified sampling cross-sectional survey
© 2022 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd..
OBJECTIVE: To investigate the management of Helicobacter pylori (H. pylori) infection by gastroenterologists from secondary and tertiary hospitals in Shandong Province, China, where there is a high prevalence of H. pylori infection.
METHODS: A questionnaire-based, stratified sampling survey was conducted from June 1 to August 30, 2021. The ratio of secondary to tertiary hospitals was set at 2:1. An electronic questionnaire was sent to the gastroenterologists via the WeChat platform.
RESULTS: A total of 89.09% (1053/1182) gastroenterologists were included. Overall, 34.19% and 60.59% of gastroenterologists recommended screening for and treating H. pylori infection in patients without any competing factors. The most preferred testing method in secondary and tertiary hospitals was the 13 C-urea breath test (53.92% and 80.48%), but the reexamination rate of results close to the cut-off value was low (55.10% and 59.48%). Gastroenterologists preferred bismuth-containing quadruple therapy (secondary and tertiary hospitals: 96.67% and 98.53%), but the antibiotic combination prescribed for patients with penicillin allergy was suboptimal in secondary hospitals. The overall post-treatment follow-up rate was 64.58%, and gastroenterologists in secondary hospitals were more proactive than those in tertiary hospitals (69.41% vs 60.04%, P = 0.001). Less than 80% of gastroenterologists emphasized the importance of post-treatment reexamination to their patients. Only a minority of gastroenterologists in secondary and tertiary hospitals (30.79% and 34.36%) achieved acceptable eradication rates (exceeding 80%).
CONCLUSIONS: Deficiencies exist in gastroenterologists from secondary and tertiary hospitals, and the H. pylori eradication rate is relatively low. Training programs for gastroenterologists are warranted to strengthen their comprehension of guidelines.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Journal of digestive diseases - 23(2022), 7 vom: 01. Juli, Seite 365-375 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Wen Lin [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 19.09.2022 Date Revised 19.09.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/1751-2980.13119 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344002365 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344002365 | ||
003 | DE-627 | ||
005 | 20231226021746.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/1751-2980.13119 |2 doi | |
028 | 5 | 2 | |a pubmed24n1146.xml |
035 | |a (DE-627)NLM344002365 | ||
035 | |a (NLM)35880374 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Wen Lin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals |b A stratified sampling cross-sectional survey |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.09.2022 | ||
500 | |a Date Revised 19.09.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. | ||
520 | |a OBJECTIVE: To investigate the management of Helicobacter pylori (H. pylori) infection by gastroenterologists from secondary and tertiary hospitals in Shandong Province, China, where there is a high prevalence of H. pylori infection | ||
520 | |a METHODS: A questionnaire-based, stratified sampling survey was conducted from June 1 to August 30, 2021. The ratio of secondary to tertiary hospitals was set at 2:1. An electronic questionnaire was sent to the gastroenterologists via the WeChat platform | ||
520 | |a RESULTS: A total of 89.09% (1053/1182) gastroenterologists were included. Overall, 34.19% and 60.59% of gastroenterologists recommended screening for and treating H. pylori infection in patients without any competing factors. The most preferred testing method in secondary and tertiary hospitals was the 13 C-urea breath test (53.92% and 80.48%), but the reexamination rate of results close to the cut-off value was low (55.10% and 59.48%). Gastroenterologists preferred bismuth-containing quadruple therapy (secondary and tertiary hospitals: 96.67% and 98.53%), but the antibiotic combination prescribed for patients with penicillin allergy was suboptimal in secondary hospitals. The overall post-treatment follow-up rate was 64.58%, and gastroenterologists in secondary hospitals were more proactive than those in tertiary hospitals (69.41% vs 60.04%, P = 0.001). Less than 80% of gastroenterologists emphasized the importance of post-treatment reexamination to their patients. Only a minority of gastroenterologists in secondary and tertiary hospitals (30.79% and 34.36%) achieved acceptable eradication rates (exceeding 80%) | ||
520 | |a CONCLUSIONS: Deficiencies exist in gastroenterologists from secondary and tertiary hospitals, and the H. pylori eradication rate is relatively low. Training programs for gastroenterologists are warranted to strengthen their comprehension of guidelines | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Helicobacter pylori | |
650 | 4 | |a eradication rate | |
650 | 4 | |a eradication therapy | |
650 | 4 | |a gastroenterologists | |
650 | 4 | |a stratified sampling | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Penicillins |2 NLM | |
650 | 7 | |a Proton Pump Inhibitors |2 NLM | |
650 | 7 | |a Amoxicillin |2 NLM | |
650 | 7 | |a 804826J2HU |2 NLM | |
650 | 7 | |a Urea |2 NLM | |
650 | 7 | |a 8W8T17847W |2 NLM | |
650 | 7 | |a Bismuth |2 NLM | |
650 | 7 | |a U015TT5I8H |2 NLM | |
700 | 1 | |a Li, Yue Yue |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Juan |e verfasserin |4 aut | |
700 | 1 | |a Wan, Meng |e verfasserin |4 aut | |
700 | 1 | |a Lin, Bo Shen |e verfasserin |4 aut | |
700 | 1 | |a Lin, Min Juan |e verfasserin |4 aut | |
700 | 1 | |a Ding, Yu Ming |e verfasserin |4 aut | |
700 | 1 | |a Kong, Qing Zhou |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shao Tong |e verfasserin |4 aut | |
700 | 1 | |a Duan, Miao |e verfasserin |4 aut | |
700 | 1 | |a Han, Zhong Xue |e verfasserin |4 aut | |
700 | 1 | |a Ji, Rui |e verfasserin |4 aut | |
700 | 1 | |a Zuo, Xiu Li |e verfasserin |4 aut | |
700 | 1 | |a Li, Yan Qing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of digestive diseases |d 2007 |g 23(2022), 7 vom: 01. Juli, Seite 365-375 |w (DE-627)NLM168045079 |x 1751-2980 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2022 |g number:7 |g day:01 |g month:07 |g pages:365-375 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/1751-2980.13119 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2022 |e 7 |b 01 |c 07 |h 365-375 |